Your browser doesn't support javascript.
loading
Identification of RBPMS as a mammalian smooth muscle master splicing regulator via proximity of its gene with super-enhancers.
Nakagaki-Silva, Erick E; Gooding, Clare; Llorian, Miriam; Jacob, Aishwarya G; Richards, Frederick; Buckroyd, Adrian; Sinha, Sanjay; Smith, Christopher W J.
Affiliation
  • Nakagaki-Silva EE; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Gooding C; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Llorian M; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Jacob AG; Francis Crick Institute, London, United Kingdom.
  • Richards F; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Buckroyd A; Anne McLaren Laboratory, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Sinha S; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
  • Smith CWJ; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Elife ; 82019 07 08.
Article in En | MEDLINE | ID: mdl-31283468
All the cells in our body contain the same genetic information, but they only switch on the genes that they need to fulfill their specific role in the organism. Genetic sequences known as enhancers can turn on the genes that are required by a particular cell to perform its tasks. Once a gene is activated, its sequence is faithfully copied into a molecule of RNA which contains segments that code for a protein. A molecular machine then processes the RNA molecule and splices together the coding segments. RNA binding proteins can also regulate this mechanism, and help to splice the coding sections in different ways depending on the type of cell. The process, known as alternative RNA splicing, therefore creates different RNA templates from the same gene. This gives rise to related but different proteins, each suited to the needs of the particular cell in which they are made. However, in some cell types, exactly how this happens has not yet been well documented. For example, in cells that line blood vessels ­ known as vascular smooth muscle cells ­ the RNA binding proteins that drive alternative splicing have not been identified. To find these proteins, Nakagaki-Silva et al. used catalogs of DNA regions called super-enhancers as clues. These sequences strongly activate certain genes in a tissue-specific manner, effectively acting as labels for genes important for a given cell type. In vascular smooth muscle cells, if a super-enhancer switches on a gene that codes for a RNA-binding protein, this protein is probably crucial for the cell to work properly. The approach highlighted a protein called RBPMS, and showed that it controlled alternative RNA splicing of many genes important in smooth muscle cells. This may suggest that when RBPMS regulation is disrupted, certain diseases of the heart and blood vessels could emerge. Finally, the results by Nakagaki-Silva et al. demonstrate that super-enhancers can signpost genes important in regulating splicing or other key processes in particular cell types.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA Splicing / Enhancer Elements, Genetic / RNA-Binding Proteins / Myocytes, Smooth Muscle / Muscle, Smooth, Vascular Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Elife Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA Splicing / Enhancer Elements, Genetic / RNA-Binding Proteins / Myocytes, Smooth Muscle / Muscle, Smooth, Vascular Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Elife Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom